CA2686033A1 - Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof - Google Patents
Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof Download PDFInfo
- Publication number
- CA2686033A1 CA2686033A1 CA002686033A CA2686033A CA2686033A1 CA 2686033 A1 CA2686033 A1 CA 2686033A1 CA 002686033 A CA002686033 A CA 002686033A CA 2686033 A CA2686033 A CA 2686033A CA 2686033 A1 CA2686033 A1 CA 2686033A1
- Authority
- CA
- Canada
- Prior art keywords
- methylpyrrolidine
- methyl
- tartrate
- pyrrolidin
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92735607P | 2007-05-03 | 2007-05-03 | |
| US60/927,356 | 2007-05-03 | ||
| PCT/US2008/005702 WO2008137087A1 (en) | 2007-05-03 | 2008-05-02 | Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2686033A1 true CA2686033A1 (en) | 2008-11-13 |
Family
ID=39688886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002686033A Abandoned CA2686033A1 (en) | 2007-05-03 | 2008-05-02 | Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof |
Country Status (14)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ574873A (en) | 2006-07-25 | 2012-03-30 | Cephalon Inc | Pyridazinone derivatives as h3 inhibitors |
| US8383657B2 (en) | 2007-12-21 | 2013-02-26 | Abbott Laboratories | Thiazolylidine urea and amide derivatives and methods of use thereof |
| EP2752406A1 (en) * | 2008-01-30 | 2014-07-09 | Cephalon, Inc. | Substituted pyridazine derivatives which have histamine H3 antagonist activity |
| US10259794B2 (en) * | 2014-12-23 | 2019-04-16 | Cephalon, Inc. | Methods for preparing fused bicyclic 2, 4-diaminopyrimidine derivatives |
| EP3847157B1 (en) * | 2018-09-07 | 2022-05-18 | Sanofi | Process for the preparation of methyl 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylate and a salt thereof |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3329974A1 (de) | 1983-08-19 | 1985-02-28 | Bayer Ag, 5090 Leverkusen | Herstellung von hydrierten nitrilkautschuken |
| DE3433392A1 (de) | 1984-09-12 | 1986-03-20 | Bayer Ag, 5090 Leverkusen | Hydrierung nitrilgruppenhaltiger ungesaettigter polymerer |
| FR2714849B1 (fr) | 1994-01-13 | 1996-04-05 | Inst Francais Du Petrole | Procédé de préparation d'un catalyseur d'hydrogénation soluble en phase liquide organique. |
| DE4403479A1 (de) | 1994-02-04 | 1995-08-10 | Basf Ag | Verfahren zur Herstellung von Hydroxylammoniumsalzen |
| WO2004024707A2 (en) * | 2002-09-16 | 2004-03-25 | Abbott Laboratories | Process for preparing amine type substituted benzofurans |
| US7153889B2 (en) | 2002-11-12 | 2006-12-26 | Abbott Laboratories | Bicyclic-substituted amines as histamine-3 receptor ligands |
| WO2005085307A1 (ja) | 2004-03-08 | 2005-09-15 | Japan Science And Technology Agency | 高分子担持金属クラスター組成物 |
| US7145005B2 (en) | 2004-05-12 | 2006-12-05 | Abbott Laboratories | 2-(6-{2-[(2R)-2-Methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one salts and their preparation |
| DE602005004404T2 (de) | 2004-06-02 | 2009-01-15 | F. Hoffmann-La Roche Ag | Als histamin-3-rezeptorliganden einsetzbare naphthalene-derivate |
| WO2006059778A1 (ja) | 2004-12-01 | 2006-06-08 | Banyu Pharmaceutical Co., Ltd. | 置換ピリドン誘導体 |
| JP2008524252A (ja) | 2004-12-17 | 2008-07-10 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Ｃｎｓ障害の処置のためのテトラヒドロイソキノリン化合物 |
| JP2008526895A (ja) | 2005-01-21 | 2008-07-24 | シェーリング コーポレイション | ヒスタミンｈ３アンタゴニストとして有用なイミダゾールおよびベンゾイミダゾール誘導体 |
| US7790720B2 (en) | 2005-03-31 | 2010-09-07 | Ucb Pharma, S.A. | Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses |
| GB0514812D0 (en) | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
| US7943605B2 (en) | 2005-10-27 | 2011-05-17 | Ucb Pharma S.A. | Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
| WO2007094962A2 (en) | 2006-02-09 | 2007-08-23 | Athersys, Inc. | Pyrazoles for the treatment of obesity and other cns disorders |
| WO2007099423A1 (en) | 2006-03-02 | 2007-09-07 | Pfizer Products Inc. | 1-pyrrolidine indane derivatives as histamine-3 receptor antagonists |
| WO2007105053A2 (en) | 2006-03-13 | 2007-09-20 | Pfizer Products Inc. | Tetralines antagonists of the h-3 receptor |
| WO2008005338A1 (en) | 2006-06-29 | 2008-01-10 | Arena Pharmaceuticals, Inc. | Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| NZ574873A (en) * | 2006-07-25 | 2012-03-30 | Cephalon Inc | Pyridazinone derivatives as h3 inhibitors |
-
2008
- 2008-05-02 CA CA002686033A patent/CA2686033A1/en not_active Abandoned
- 2008-05-02 CN CN200880021225A patent/CN101679237A/zh active Pending
- 2008-05-02 EP EP08754205A patent/EP2152669A1/en not_active Withdrawn
- 2008-05-02 NZ NZ580948A patent/NZ580948A/en not_active IP Right Cessation
- 2008-05-02 KR KR1020097025141A patent/KR20100017565A/ko not_active Ceased
- 2008-05-02 BR BRPI0810330-5A2A patent/BRPI0810330A2/pt not_active IP Right Cessation
- 2008-05-02 WO PCT/US2008/005702 patent/WO2008137087A1/en active Application Filing
- 2008-05-02 MX MX2009011787A patent/MX2009011787A/es active IP Right Grant
- 2008-05-02 UA UAA200912476A patent/UA99913C2/ru unknown
- 2008-05-02 EA EA200971019A patent/EA019031B1/ru not_active IP Right Cessation
- 2008-05-02 JP JP2010507416A patent/JP5698887B2/ja not_active Expired - Fee Related
- 2008-05-02 AU AU2008248168A patent/AU2008248168B2/en not_active Ceased
-
2009
- 2009-10-19 IL IL201627A patent/IL201627A/en not_active IP Right Cessation
- 2009-10-30 ZA ZA2009/07643A patent/ZA200907643B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA200971019A1 (ru) | 2010-04-30 |
| CN101679237A (zh) | 2010-03-24 |
| IL201627A0 (en) | 2010-05-31 |
| KR20100017565A (ko) | 2010-02-16 |
| AU2008248168A1 (en) | 2008-11-13 |
| MX2009011787A (es) | 2009-11-13 |
| NZ580948A (en) | 2011-04-29 |
| BRPI0810330A2 (pt) | 2014-10-14 |
| EP2152669A1 (en) | 2010-02-17 |
| IL201627A (en) | 2014-06-30 |
| WO2008137087A1 (en) | 2008-11-13 |
| AU2008248168B2 (en) | 2013-03-21 |
| JP5698887B2 (ja) | 2015-04-08 |
| JP2010526142A (ja) | 2010-07-29 |
| UA99913C2 (ru) | 2012-10-25 |
| EA019031B1 (ru) | 2013-12-30 |
| ZA200907643B (en) | 2014-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20100121055A1 (en) | Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof | |
| JP6491393B2 (ja) | ヒストン脱アセチル化酵素６阻害剤としての１，３，４−オキサジアゾール誘導体化合物及びこれを含有する薬剤学的組成物 | |
| JP6392888B2 (ja) | ヒストン脱アセチル化酵素６阻害剤としての新規化合物およびこれを含む薬剤学的組成物 | |
| CN103354808B (zh) | 抗病毒化合物 | |
| JP6117430B2 (ja) | 選択的ヒストン脱アセチル化酵素抑制剤としての新規化合物およびこれを含む薬剤学的組成物 | |
| RU2351589C2 (ru) | Производные n-[фенил(алкилпиперидин-2-ил)метил]бензамида и их применение в терапии | |
| Wallace et al. | Development of a fit-for-purpose large-scale synthesis of an oral PARP inhibitor | |
| WO2000017163A1 (fr) | Derives de cyanophenyle | |
| AU1679099A (en) | 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists | |
| AU2021308344B2 (en) | Novel compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the same | |
| CA2686033A1 (en) | Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof | |
| JP2012519196A (ja) | スルホニル化されたテトラヒドロアゾロピラジンおよびその医薬としての使用 | |
| ZA200603861B (en) | Use of tricyclic compounds as glycine transport inhibitors | |
| KR20100093103A (ko) | 고지혈증 또는 동맥경화증과 같은 질환의 치료에 유용한 ｃετρ 억제제로서의 1,2-이치환된 4-벤질아미노-피롤리딘 유도체 | |
| KR20230158007A (ko) | 항바이러스 화합물 | |
| CA2791431A1 (en) | Derivatives of aminoindanes, their preparation and their application in therapeutics | |
| ZA200407414B (en) | Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially CCR5). | |
| CN114728177A (zh) | 作为Kv1.3钾Shaker通道阻滞剂的芳基杂二环化合物 | |
| CA2500115A1 (en) | Heterocyclic substituted piperazines for the treatment of schizophrenia | |
| García‐Mingüens et al. | Nitroprolinates as Nucleophiles in Michael‐type Additions and Acylations. Synthesis of Enantiomerically Enriched Fused Amino‐pyrrolidino‐[1, 2‐a] pyrazinones and‐diketopiperazines | |
| JP2010526142A5 (enrdf_load_stackoverflow) | ||
| Vega-Penaloza et al. | Stereoselective synthesis of chiral pyrrolidine derivatives of (+)-α-pinene containing a β-amino acid moiety | |
| AU2006316609A1 (en) | Modulators of the H3 receptor useful for the treatment of disorders related thereto | |
| ZA200700950B (en) | Pyrrole derivatives, their preparation and their therapeutic use | |
| Shen et al. | Asymmetric Synthesis of γ-Amino-Functionalised Vinyl Sulfones: De Novo Preparation of Cysteine Protease Inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20130319 |
|
| FZDE | Discontinued |
Effective date: 20160504 |